Global Study on Pharmaceutical Excipients Market, 2015-2021
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
<str<strong>on</strong>g>Global</str<strong>on</strong>g> <str<strong>on</strong>g>Study</str<strong>on</strong>g> <strong>on</strong> <strong>Pharmaceutical</strong> <strong>Excipients</strong> <strong>Market</strong>, <strong>2015</strong>-<strong>2021</strong><br />
Persistence <strong>Market</strong> Research<br />
<str<strong>on</strong>g>Global</str<strong>on</strong>g> <strong>Pharmaceutical</strong> Excipient <strong>Market</strong> to<br />
Reach US$ 7,415.2 Mn by <strong>2021</strong>: Persistence<br />
<strong>Market</strong> Research<br />
Persistence <strong>Market</strong> Research 1
<str<strong>on</strong>g>Global</str<strong>on</strong>g> <str<strong>on</strong>g>Study</str<strong>on</strong>g> <strong>on</strong> <strong>Pharmaceutical</strong> <strong>Excipients</strong> <strong>Market</strong>, <strong>2015</strong>-<strong>2021</strong><br />
Persistence <strong>Market</strong> Research Released New <strong>Market</strong> Report According to a new market report<br />
published by Persistence <strong>Market</strong> Research “<str<strong>on</strong>g>Global</str<strong>on</strong>g> <strong>Market</strong> <str<strong>on</strong>g>Study</str<strong>on</strong>g> <strong>on</strong> <strong>Pharmaceutical</strong><br />
<strong>Excipients</strong>: Increased Drug Demand in Emerging Asia Pacific <strong>Market</strong> to Fuel<br />
Demand Multi-Functi<strong>on</strong>al <strong>Excipients</strong>”, revenue from the global pharmaceutical<br />
excipients market is expected to expand at a CAGR of 6.7% during the forecast period <strong>2015</strong> -<br />
<strong>2021</strong>.<br />
In the report, the global pharmaceutical excipients market is analyzed <strong>on</strong> the basis of<br />
chemistry type (i.e. source of origin), applicati<strong>on</strong> type, functi<strong>on</strong>ality, and regi<strong>on</strong>. Based <strong>on</strong><br />
chemistry type, the overall market has been segmented into plant-based, animal-based,<br />
mineral-based and synthetically derived excipients. Based <strong>on</strong> functi<strong>on</strong>ality, the market has<br />
been segmented into binders (binders, coatings, and fillers), glidents, diluents, disintegrants,<br />
and others (solvents, co-solvents, anti-microbial agents, lubricants, colorants, emulsifiers,<br />
and humectants). By applicati<strong>on</strong> type, the market has been segmented into oral, topical,<br />
parenteral formulati<strong>on</strong>s, and others, which includes suppositories, intra-muscular, and<br />
ophthalmic preparati<strong>on</strong>s. In the overall market, oral solid dosage formulati<strong>on</strong>s are expected<br />
to witness increased uptake owing to the ease of c<strong>on</strong>sumpti<strong>on</strong> by patients globally.<br />
Accordingly, oral applicati<strong>on</strong> type segment is expected to witness value increase from US$<br />
3,327.8 Mn in <strong>2015</strong> to US$ 5,094.2 Mn by the end of <strong>2021</strong>.<br />
The prime drivers of the market include rising demand for sustained-release and c<strong>on</strong>trolledrelease<br />
formulati<strong>on</strong>s, especially in oral applicati<strong>on</strong>s, and increased demand for generics.<br />
Sustained and extended release formulati<strong>on</strong>s are gaining popularity as they help in<br />
maintaining patient-safety through reduced number of medicine dosages, but having<br />
increased drug efficacy. Apart from these factors, increase in the incidence of chr<strong>on</strong>ic<br />
diseases across regi<strong>on</strong>s has been spurring demand for essential drugs, which is expected to<br />
fuel demand for excipients over the forecast period.<br />
Frequent physical audits of excipients manufacturing facilities by officials from regulatory<br />
agencies lead to the impositi<strong>on</strong> of substantial operating cost burdens <strong>on</strong> excipient<br />
manufacturers, thus hampering revenue growth for excipients over the forecast period.<br />
Other market deterrents include l<strong>on</strong>g gestati<strong>on</strong> period before a novel excipient is formally<br />
accepted in the industry. However, the situati<strong>on</strong> is expected to improve over the next few<br />
years, with individual ec<strong>on</strong>omies formulating their own good manufacturing and good<br />
Persistence <strong>Market</strong> Research 2
<str<strong>on</strong>g>Global</str<strong>on</strong>g> <str<strong>on</strong>g>Study</str<strong>on</strong>g> <strong>on</strong> <strong>Pharmaceutical</strong> <strong>Excipients</strong> <strong>Market</strong>, <strong>2015</strong>-<strong>2021</strong><br />
distributi<strong>on</strong> practice guidelines in collaborati<strong>on</strong> with the Internati<strong>on</strong>al <strong>Pharmaceutical</strong><br />
Excipient Council.<br />
Based <strong>on</strong> regi<strong>on</strong>s, the market has been divided into North America, Latin America, Europe,<br />
Asia-Pacific, and the MEA. Developed pharmaceutical markets such as the U.S. and EU are<br />
expected to emerge as the main sourcing markets, while ec<strong>on</strong>omies such as India, China,<br />
and Brazil are expected to emerge as the main supplying countries for raw materials such as<br />
cellulose, starch, lactose, etc.<br />
Formalizati<strong>on</strong> of good manufacturing practices for excipients is an urgent need in the global<br />
excipients market, in order to cater to rising demand for higher purity excipients in<br />
applicati<strong>on</strong>s such as parenteral forms. According to various trade associati<strong>on</strong>s and<br />
regulatory agencies, global acceptance of excipients by drug manufacturers is a relatively<br />
lengthy process, which takes around seven to 10 years. This factor is expected to prol<strong>on</strong>g<br />
the revenue c<strong>on</strong>versi<strong>on</strong> period for excipients manufacturers.<br />
Request Sample Report: http://www.persistencemarketresearch.com/samples/4421<br />
This report assesses trends by chemistry type, applicati<strong>on</strong> type, functi<strong>on</strong>alities and regi<strong>on</strong>s<br />
to offer analytical insights about the potential demand emerging for particular<br />
pharmaceutical excipients in specific regi<strong>on</strong>s. North America is estimated to dominate the<br />
pharmaceutical excipients market accounting for a maximum revenue share of the overall<br />
market by the end of <strong>2015</strong>. By <strong>2021</strong> end, North America and Europe markets are expected<br />
to account for over three-fifth share of the global pharmaceutical excipients market revenue.<br />
In terms of market share by value, North America is estimated to retain its dominant<br />
positi<strong>on</strong>, registering a CAGR of 6.9% over the forecast period.<br />
View Detail Report With TOC: http://www.persistencemarketresearch.com/marketresearch/pharmaceutical-excipients-market.asp<br />
Some key companies covered in this report include BASF SE, Ev<strong>on</strong>ik Industries AG, Innophos<br />
Holdings Inc., The Lubrizol Corporati<strong>on</strong>, The Dow Chemical Company, Wacker Chemie AG,<br />
and Ashland Inc. These companies are primarily focused <strong>on</strong> enhancing their product portfolio<br />
Persistence <strong>Market</strong> Research 3
<str<strong>on</strong>g>Global</str<strong>on</strong>g> <str<strong>on</strong>g>Study</str<strong>on</strong>g> <strong>on</strong> <strong>Pharmaceutical</strong> <strong>Excipients</strong> <strong>Market</strong>, <strong>2015</strong>-<strong>2021</strong><br />
through research and development and the introducti<strong>on</strong> of innovative and cost-effective<br />
advanced manufacturing procedures such as co-processing of existing excipients in order to<br />
gain higher market share and to strengthen their respective positi<strong>on</strong>s in the global market.<br />
For more Info: http://www.persistencemarketresearch.com/c<strong>on</strong>tact-us.asp<br />
The global pharmaceutical excipients market is segmented as follows:<br />
By Source of Origin<br />
<br />
<br />
<br />
<br />
Plant-based excipients<br />
Animal-based excipients<br />
Mineral-based excipients<br />
Synthetic excipients<br />
By Applicati<strong>on</strong> Type<br />
<br />
<br />
<br />
<br />
Oral Formulati<strong>on</strong><br />
Topical Formulati<strong>on</strong><br />
Parenteral Formulati<strong>on</strong><br />
Others<br />
By Functi<strong>on</strong>ality<br />
<br />
<br />
<br />
<br />
<br />
Binders<br />
Glidents<br />
Diluents<br />
Disintegrants<br />
Others<br />
Persistence <strong>Market</strong> Research 4
<str<strong>on</strong>g>Global</str<strong>on</strong>g> <str<strong>on</strong>g>Study</str<strong>on</strong>g> <strong>on</strong> <strong>Pharmaceutical</strong> <strong>Excipients</strong> <strong>Market</strong>, <strong>2015</strong>-<strong>2021</strong><br />
By Regi<strong>on</strong><br />
<br />
<br />
<br />
<br />
<br />
North America<br />
Latin America<br />
Europe<br />
Asia Pacific<br />
Middle East & Africa<br />
<strong>Market</strong> History:<br />
<strong>Pharmaceutical</strong> excipients are substances other than pharmacologically active drug<br />
comp<strong>on</strong>ents, which are included in the drug manufacturing process or c<strong>on</strong>tained in a<br />
finished pharmaceutical product dosage form. They facilitate formulati<strong>on</strong> design and perform<br />
a range of functi<strong>on</strong>s such as increasing lubricity, enhancing flowability and improving<br />
compressibility, am<strong>on</strong>g other characteristics. The global market for pharmaceutical<br />
excipients has been segmented based <strong>on</strong> the source of origin or chemistry type as per U.S.<br />
pharmacopeia, i.e. plant-based, animal-based, mineral-based and synthetically derived<br />
excipients. The market has also been segmented by applicati<strong>on</strong> type and functi<strong>on</strong>ality of<br />
various excipients, and by regi<strong>on</strong>s.<br />
The global pharmaceutical excipients market is estimated to be valued at US$ 7,415.2 Mn by<br />
<strong>2021</strong> end, with various markets registering significant CAGRs during the forecast period.<br />
The growth of the global pharmaceutical excipients market is mainly driven by increasing<br />
demand for drugs that can be c<strong>on</strong>sumed orally. Ease of c<strong>on</strong>sumpti<strong>on</strong> and associated patient<br />
comfort has been pushing big drug makers to develop sustained-release dosage<br />
formulati<strong>on</strong>s. This also c<strong>on</strong>tributes to extended shelf life of oral drugs, which adds to higher<br />
revenue prospects. However, n<strong>on</strong>-availability of harm<strong>on</strong>ized quality standards for gradati<strong>on</strong><br />
of excipients and their safety evaluati<strong>on</strong> standards are some factors expected to restrain the<br />
growth of the market over the forecast period.<br />
Internati<strong>on</strong>al regulatory benchmarking for uniform good manufacturing and distributi<strong>on</strong><br />
practices for excipients, spanning regi<strong>on</strong>s, is set to define the market landscape of the<br />
Persistence <strong>Market</strong> Research 5
<str<strong>on</strong>g>Global</str<strong>on</strong>g> <str<strong>on</strong>g>Study</str<strong>on</strong>g> <strong>on</strong> <strong>Pharmaceutical</strong> <strong>Excipients</strong> <strong>Market</strong>, <strong>2015</strong>-<strong>2021</strong><br />
excipient industry over the forecast period. This is expected to be accompanied by<br />
standardized documentati<strong>on</strong>, and approval and pharmacovigilance activities related to these<br />
inactive ingredients.<br />
Based <strong>on</strong> chemistry type, the market has been segmented into plant-based, animal-based,<br />
mineral-based, and synthetically derived. <str<strong>on</strong>g>Global</str<strong>on</strong>g>ly, naturally derived excipients are<br />
witnessing increased demand due to lesser side effects, such as flatulence, skin rashes, etc.<br />
and improved compositi<strong>on</strong> quality. In terms of value, the plant-based excipient is estimated<br />
to account for close to <strong>on</strong>e-third of the global market share by <strong>2021</strong> end. The segment is<br />
expected to gain market attractiveness throughout the forecast period. The principle plantbased<br />
excipients expected to witness increased demand are microcrystalline cellulose<br />
(MCC), starch, and starch-derivatives. They would find primary applicati<strong>on</strong> in oral<br />
formulati<strong>on</strong>s.<br />
Based <strong>on</strong> applicati<strong>on</strong>, the market has been segmented into oral, topical, parenteral<br />
formulati<strong>on</strong>s, and others. Others segment includes less frequently used drug delivery<br />
methods such as suppositories, intra-muscular, transdermal, ophthalmic, etc. Lack of highly<br />
developed c<strong>on</strong>trolled manufacturing facilities and fear of anti-microbial c<strong>on</strong>taminati<strong>on</strong> is<br />
expected to deter the development of excipients such as solvents and co-solvents in certain<br />
regi<strong>on</strong>s over the forecast period.<br />
Based <strong>on</strong> functi<strong>on</strong>ality, the global excipient market has been segmented into binders,<br />
diluents, glidents, disintegrants, and others (solvents, co-solvents, anti-microbial agents,<br />
humectants, colorants, sweeteners, etc.). The binders functi<strong>on</strong>ality segment, c<strong>on</strong>sisting of<br />
binders, fillers, and coating agents are primarily used in oral solid dosage formulati<strong>on</strong>s and is<br />
expected to account for close to 50% of the total excipient market by value over the forecast<br />
period. The segment is expected to be valued at US$ 3,523.8 Mn by <strong>2021</strong> end, registering a<br />
significant CAGR over the forecast period.<br />
The global pharmaceutical excipients market has been segmented into five major regi<strong>on</strong>s<br />
namely North America, Latin America, Europe, Asia-Pacific, and the Middle East & Africa. In<br />
terms of value, North America is estimated to be dominant, accounting for over <strong>on</strong>e-third of<br />
the total excipients market value by <strong>2015</strong> end. Asia Pacific is estimated to emerge as the<br />
fastest growing market am<strong>on</strong>g all the emerging regi<strong>on</strong>s while revenue from the market in<br />
Persistence <strong>Market</strong> Research 6
<str<strong>on</strong>g>Global</str<strong>on</strong>g> <str<strong>on</strong>g>Study</str<strong>on</strong>g> <strong>on</strong> <strong>Pharmaceutical</strong> <strong>Excipients</strong> <strong>Market</strong>, <strong>2015</strong>-<strong>2021</strong><br />
Europe is expected to expand at a healthy CAGR of 6.1% over the forecast period despite<br />
the <strong>on</strong>going ec<strong>on</strong>omic downturn in the regi<strong>on</strong>.<br />
Some of the key players covered in the global pharmaceutical excipients drug market report<br />
are BASF SE, Ev<strong>on</strong>ik Industries AG, Innophos Holdings Inc., The Lubrizol Corporati<strong>on</strong>, The<br />
Dow Chemical Company, Wacker Chemie AG, and Ashland Inc. The report is enriched<br />
through identificati<strong>on</strong> of company-specific strategies related to excipient raw material<br />
sourcing, research and development, market c<strong>on</strong>solidati<strong>on</strong> initiatives, and analyzes of the<br />
various market player’s specific strengths, weaknesses, opportunities, and threats.<br />
Follow us <strong>on</strong> Linkedin: https://www.linkedin.com/company/persistence-market-research-&-c<strong>on</strong>sulting<br />
About Us:<br />
Persistence <strong>Market</strong> Research (PMR) is a full-service market intelligence firm specializing in syndicated<br />
research, custom research, and c<strong>on</strong>sulting services. PMR boasts market research expertise across the<br />
Healthcare, Chemicals and Materials, Technology and Media, Energy and Mining, Food and Beverages,<br />
Semic<strong>on</strong>ductor and Electr<strong>on</strong>ics, C<strong>on</strong>sumer Goods, and Shipping and Transportati<strong>on</strong> industries. The<br />
Persistence <strong>Market</strong> Research 7
<str<strong>on</strong>g>Global</str<strong>on</strong>g> <str<strong>on</strong>g>Study</str<strong>on</strong>g> <strong>on</strong> <strong>Pharmaceutical</strong> <strong>Excipients</strong> <strong>Market</strong>, <strong>2015</strong>-<strong>2021</strong><br />
company draws from its multi-disciplinary capabilities and high-pedigree team of analysts to share data<br />
that precisely corresp<strong>on</strong>ds to clients’ business needs.<br />
C<strong>on</strong>tact Us:<br />
Persistence <strong>Market</strong> Research<br />
305 Broadway<br />
7th Floor, New York City,<br />
NY 10007, United States,<br />
USA - Canada Toll Free: 800-961-0353<br />
Email: sales@persistencemarketresearch.com<br />
Web: http://www.persistencemarketresearch.com<br />
Persistence <strong>Market</strong> Research 8